Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotransplant(BTRN) -- Ignore unavailable to you. Want to Upgrade?

To: Arthur Radley who wrote (304)	7/2/1999 11:54:00 AM
From: scaram(o)uche	Read Replies (1) \| Respond to of 1475

TD: Haven't a clue. Tough indication, trauma. Meningo I feel more confident about, but still feel that it's a crap shoot. Too risky for my taste, but I sure would have liked to have been along on this most recent run. In a sense, anti-CD11a modulates the risk. OTOH, there are other really strong approaches to psoriasis. BTRN..... yeah...... long, tough "stick with". In general, if one finds good science that is discounted to a value of $0, your investment is safe. However, it's nice to see a value assigned and actually see the investment appreciate. Safe is nice, appreciation is better. - g - Outta here for a week. Good luck! Rick